[go: up one dir, main page]

Solomon, 2004 - Google Patents

Alzheimer's disease and immunotherapy

Solomon, 2004

Document ID
17119526341352627577
Author
Solomon B
Publication year
Publication venue
Current Alzheimer Research

External Links

Snippet

Site-directed antibodies which modulate conformation of β-amyloid peptide became the theoretical basis of the immunological approach for treatment of Alzheimer's disease (AD). Indeed, antibodies towards the EFRH sequence, located between amino acids 3-6 of the N …
Continue reading at www.ingentaconnect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Solomon Alzheimer's disease and immunotherapy
JP5736565B2 (en) Prevention and treatment of SYNUCLEIN disease
Moreth et al. Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
Sigurdsson Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies
EP1989308B1 (en) Methods and compositions to treat and detect misfolded-sod1 mediated diseases
KR20070042566A (en) Prevention and treatment of synuclein and amyloidogenic diseases
NO346055B1 (en) Antigen design, vaccine composition and method of manufacture thereof.
Solomon Immunological approaches as therapy for Alzheimer’s disease
Woodhouse et al. Vaccination strategies for Alzheimer’s disease: A new hope?
Solomon et al. Immunotherapy for Alzheimer’s disease
Southwell et al. Antibody therapy in neurodegenerative disease
Solomon Anti-aggregating antibodies, a new approach towards treatment of conformational diseases
Solomon Immunotherapeutic Strategies for Alzheimer′ s Disease Treatment
Solomon Alzheimer's disease immunotherapy: from in vitro amyloid immunomodulation to in vivo vaccination
Oluwasanmi Adeloye et al. Amyloid-β immunotherapy on alzheimer disease: Prevention and therapeutic target
JP4937143B2 (en) Method for detecting autoantibodies having specificity for non-diffusible globular Aβ (X-38..43) oligomeric structural epitopes
Fuller Improving immunotherapy for Alzheimer’s Disease-determining the role of effector function in the clearance of plaques and neuro-inflammatory response
Karlnoski Optimization of anti-Abeta antibody therapy
Ikezu Immunotherapy for Alzheimer’s disease
Schroeder Tau-Directed Immunotherapy for Alzheimer's Disease
Chukwu Epitope conformation and targeting of phosphorylated tau protein
Solomon Peptide Vaccine for Alzheimer's Disease
Yang et al. Immunotherapeutic approaches against amyloid-β in drug discovery for alzheimer’s disease
Agadjanyan et al. A Multitep platform-based epitope vaccine targeting the phosphatase activating domain (pAD) of tau: therapeutic efficacy in PS19 mice
HK1124885B (en) Methods and compositions to treat and detect misfolded-sod1 mediated diseases